Rabies virus glycoprotein as a carrier for anthrax protective antigen
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Chimeric Influenza Virus Hemagglutinin Proteins Containing Large Domains of the Bacillus anthracis Protective Antigen: Protein Characterization, Incorporation into Infectious Influenza Viruses, and AntigenicityJournal of Virology, 2005
- Combining Anthrax Vaccine and Therapy: a Dominant-Negative Inhibitor of Anthrax Toxin Is Also a Potent and Safe Immunogen for VaccinesInfection and Immunity, 2005
- Mass Value Assignment of Total and Subclass Immunoglobulin G in a Human Standard Anthrax Reference SerumClinical and Vaccine Immunology, 2004
- Protective Immunity Evoked Against Anthrax Lethal Toxin After a Single Intramuscular Administration of an Adenovirus-Based Vaccine Encoding Humanized Protective AntigenHuman Gene Therapy, 2003
- Mucosal or Parenteral Administration of Microsphere-Associated Bacillus anthracis Protective Antigen Protects against Anthrax Infection in MiceInfection and Immunity, 2002
- Rabies Virus-Based Vectors Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Protein Induce a Strong, Cross-Reactive Cytotoxic T-Lymphocyte Response against Envelope Proteins from Different HIV-1 IsolatesJournal of Virology, 2001
- Dominant-Negative Mutants of a Toxin Subunit: An Approach to Therapy of AnthraxScience, 2001
- Long-Term Humoral and Cellular Immunity after Vaccination with Cell Culture Rabies Vaccines in ManClinical Immunology and Immunopathology, 1994
- Sequence and analysis of the DNA encoding protective antigen of Bacillus anthracisGene, 1988
- Differential effects of mutations in three domains on folding, quaternary structure, and intracellular transport of vesicular stomatitis virus G protein.Journal of Cell Biology, 1988